[171] According to a 2025 review, the discontinuation of amphetamine at therapeutic doses does not typically result in withdrawal symptoms
2 Nevertheless, it has been found that despite eight available families of hypoglycemic compounds (biguanides, sulfonylureas, glinides, -glucosidase inhibitors, DPPIV inhibitors, GLP1 analogues, thiazolidinediones, and SGLT2 inhibitors), 3.0.CO;2-W 9
[5] This gene encodes a member of the glutathione peroxidase family
The research suggests that glutathione can interrupt an enzyme within the skins surface layers that triggers hyperpigmentation
Zepbound (tirzepatide) On February 23, 2026, Novo Nordisk shared results from a study that directly compared CagriSema to Zepbound